Are you over 18 and want to see adult content?
More Annotations
![A complete backup of coolmoviesfree.blogspot.com](https://www.archivebay.com/archive/54c7aaa1-6994-478c-835c-c5e4bfa1f17c.png)
A complete backup of coolmoviesfree.blogspot.com
Are you over 18 and want to see adult content?
![A complete backup of eatlikenoone.com](https://www.archivebay.com/archive/ee4cea7a-9df9-4038-8425-e894384d2850.png)
A complete backup of eatlikenoone.com
Are you over 18 and want to see adult content?
![A complete backup of werkenbijvanharen.nl](https://www.archivebay.com/archive/9201f3fd-6f37-470a-82f4-06cdd58c1273.png)
A complete backup of werkenbijvanharen.nl
Are you over 18 and want to see adult content?
![A complete backup of thecustomsabershop.com](https://www.archivebay.com/archive/29e118be-6581-4dc3-8ea7-02d8aaf50204.png)
A complete backup of thecustomsabershop.com
Are you over 18 and want to see adult content?
![A complete backup of globalprpool.com](https://www.archivebay.com/archive/dbfb9309-607a-427d-933b-8503e8ebf473.png)
A complete backup of globalprpool.com
Are you over 18 and want to see adult content?
Favourite Annotations
![A complete backup of yourdorkbrains.com](https://www.archivebay.com/archive/3154391e-7111-4e13-938e-42ab86c69029.png)
A complete backup of yourdorkbrains.com
Are you over 18 and want to see adult content?
![Биробиджан - Город на Бире - портал «Город на Бире» (г. Биробиджан)](https://www.archivebay.com/archive/8187672d-e75d-4ee6-bb26-d3728fec359e.png)
Биробиджан - Город на Бире - портал «Город на Бире» (г. Биробиджан)
Are you over 18 and want to see adult content?
![La Tienda de Muebles Online y Decoración nº 1 de España - Portobellostreet.es](https://www.archivebay.com/archive/4ac22da3-71a5-4c89-9a96-5bd849c853de.png)
La Tienda de Muebles Online y Decoración nº 1 de España - Portobellostreet.es
Are you over 18 and want to see adult content?
![Paraíba hoje M@is Notícias | Marconi Lucena](https://www.archivebay.com/archive/598c555e-c897-4875-bba1-6d62093e91ae.png)
Paraíba hoje M@is Notícias | Marconi Lucena
Are you over 18 and want to see adult content?
![DuetsBlog | Creativity & the Law | Winthrop & Weinstine Intellectual Property Attorneys](https://www.archivebay.com/archive/14655b17-062f-4caf-aba9-6bf20b854109.png)
DuetsBlog | Creativity & the Law | Winthrop & Weinstine Intellectual Property Attorneys
Are you over 18 and want to see adult content?
Text
CNS and
KYOWA KIRIN INTERNATIONAL Kyowa Kirin Pharma S.R.L. pursuant to Section 54 (1) of the Modern Slavery Act 2015 (the “Act”) and covers the financial year ending 31 December 2019. KKI is a wholly owned subsidiary of Kyowa Kirin Co., Ltd. a company incorporated in Japan and listed on the Tokyo Stock Exchange. The Kyowa Kirin Group is an R&D based pharmaceutical companyKYOWA KIRIN LTD
Welcome to Kyowa Kirin Ltd (UK and Ireland) Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. KYOWA KIRIN INTERNATIONAL Kyowa Kirin. A global company committed to taking the walk of life, one life at a time. We bring innovative pharmaceuticals to the world. We are devoted to developing innovative antibody engineering technology by pursuing the truth of life more deeply. "Therapeutic Antibodies" Hopes for the Future. We are driven by state-of-the-artantibody
KYOWA KIRIN INTERNATIONAL Kyowa Kirin è una azienda farmaceutica globale con sede in Giappone, che vuole contribuire alla salute e al benessere attraverso lo sviluppo e la commercializzazione nel mondo di farmaci innovativi, ponendosi all’avanguardia nel settore dell’immunoterapia e della ricerca di nuovi anticorpi terapeutici. KYOWA KIRIN INTERNATIONAL Here is the top of page. This is the navigation link for moving toward in this page. Go to main contents; Go to footer contents HOME - KYOWA KIRIN LTDTRANSLATE THIS PAGE Waar patiënten kunnen gelovenin een toekomst zonder pijn. Commitment to life. One life at a time. Bij Kyowa Kirin geloven we in een wereld waarin niemand hoeft te lijden. We begrijpen dat wij als farmaceut de wereld als geheel niet kunnen veranderen. We kunnen wél die van de patiënt en hun familie en vrienden veranderen. En daar gaat het om. KYOWA KIRIN INTERNATIONAL Nachstehend finden Sie die Kontaktinformationen unserer Kyowa Kirin Niederlassung in der Schweiz. Dr. Kirsten Wittling. Kyowa Kirin Sàrl Rue Philippe-Plantamour 18-20 c/o Intertrust (Suisse) SA KYOWA KIRIN INTERNATIONAL Kyowa Kirin Farmacêutica, Unipessoal LDA. Avenida da Ilha da Madeira, nº 35I – 2ºA. Restelo Business Center. 1400-203 Lisboa, Portugal. TEL: +351 21 870 0002. Informação Médica ou Informações Gerais: infoPT@kyowakirin.com. Pharmacovigilance: Farmacovigilância –Efeitos adversos:
KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. Kyowa Kirin International is a subsidiary of Kyowa Kirin Co., Ltd. the Japan-based global specialty pharmaceutical KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is owned by Kyowa Kirin Co., Ltd. of Japan. Founded in 1949, Kyowa Kirin has a successful track record in Japan and is now expanding globally. Our highly successful product portfolio, enviable pipeline and active Business Development group provides a wealth of products in the therapeutic areas of Oncology,CNS and
KYOWA KIRIN INTERNATIONAL Kyowa Kirin Pharma S.R.L. pursuant to Section 54 (1) of the Modern Slavery Act 2015 (the “Act”) and covers the financial year ending 31 December 2019. KKI is a wholly owned subsidiary of Kyowa Kirin Co., Ltd. a company incorporated in Japan and listed on the Tokyo Stock Exchange. The Kyowa Kirin Group is an R&D based pharmaceutical companyKYOWA KIRIN LTD
Welcome to Kyowa Kirin Ltd (UK and Ireland) Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. KYOWA KIRIN INTERNATIONAL Kyowa Kirin. A global company committed to taking the walk of life, one life at a time. We bring innovative pharmaceuticals to the world. We are devoted to developing innovative antibody engineering technology by pursuing the truth of life more deeply. "Therapeutic Antibodies" Hopes for the Future. We are driven by state-of-the-artantibody
KYOWA KIRIN INTERNATIONAL Kyowa Kirin è una azienda farmaceutica globale con sede in Giappone, che vuole contribuire alla salute e al benessere attraverso lo sviluppo e la commercializzazione nel mondo di farmaci innovativi, ponendosi all’avanguardia nel settore dell’immunoterapia e della ricerca di nuovi anticorpi terapeutici. KYOWA KIRIN INTERNATIONAL Here is the top of page. This is the navigation link for moving toward in this page. Go to main contents; Go to footer contents HOME - KYOWA KIRIN LTDTRANSLATE THIS PAGE Waar patiënten kunnen gelovenin een toekomst zonder pijn. Commitment to life. One life at a time. Bij Kyowa Kirin geloven we in een wereld waarin niemand hoeft te lijden. We begrijpen dat wij als farmaceut de wereld als geheel niet kunnen veranderen. We kunnen wél die van de patiënt en hun familie en vrienden veranderen. En daar gaat het om. KYOWA KIRIN INTERNATIONAL Nachstehend finden Sie die Kontaktinformationen unserer Kyowa Kirin Niederlassung in der Schweiz. Dr. Kirsten Wittling. Kyowa Kirin Sàrl Rue Philippe-Plantamour 18-20 c/o Intertrust (Suisse) SA KYOWA KIRIN INTERNATIONAL Kyowa Kirin Farmacêutica, Unipessoal LDA. Avenida da Ilha da Madeira, nº 35I – 2ºA. Restelo Business Center. 1400-203 Lisboa, Portugal. TEL: +351 21 870 0002. Informação Médica ou Informações Gerais: infoPT@kyowakirin.com. Pharmacovigilance: Farmacovigilância –Efeitos adversos:
KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is owned by Kyowa Kirin Co., Ltd. of Japan. Founded in 1949, Kyowa Kirin has a successful track record in Japan and is now expanding globally. Our highly successful product portfolio, enviable pipeline and active Business Development group provides a wealth of products in the therapeutic areas of Oncology,CNS and
KYOWA KIRIN INTERNATIONAL Here is the top of page. This is the navigation link for moving toward in this page. Go to main contents; Go to footer contents PRODUCTS – KYOWA KIRIN LTD All Kyowa Kirin products are produced using cutting-edge manufacturing technology equipment and under our strict quality assurance system and in full compliance with global standards. Please click here to find out more about our products. KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is a company with many career avenues in Europe and the US. We need you, with the drive to excel to join us and contribute to our impressive successes and continued growth. KYOWA KIRIN INTERNATIONAL Kyowa Hakko Kirin Business Vision. Kyowa Hakko Kirin will be a Japan-based Global Specialty Pharmaceutical Company contributing to human health and well-being worldwide through innovative drug discovery and global commercialization, driven by state-of-the art antibody technologies mainly in the core therapeutic areas of oncology, nephrology and CRYSVITA PRODUCT MONOGRAPH The recommended starting dose regimen is 0.8mg/kg of body weight, rounded to the nearest 10mg, administered every two weeks. The minimum starting dose is 10 mg up to a maximum dose of 90mg. KYOWA KIRIN INTERNATIONAL Kyowa Kirin International - Kyowa Kirin Dubai. Below is the contact information for Dubai office. Kyowa Kirin Pharma FZ-LLC. Office 106, Building 49, Dubai Healthcare City, Dubai, United Arab Emirates. PO Box 62468. T: +971 4 581 3700. OUR VALUES – KYOWA KIRIN LTD Our values are the foundation of our success and are reflected in the strength and dedication demonstrated by our team every day. We inspire and challenge our people to think creatively and work together to create a better world and help people live healthier, more fulfilling lives. We cultivate a strong culture and provide a workingCURRENT VACANCIES
Kyowa Kirin Ltd. Head Office Galabank Business Park Galashiels TD1 1QH United Kingdom. Tel: +44 (0)1896 664 000 Email:TRANSPARENCY
Financial Declaration. Kyowa Kirin Ltd. is committed to supporting healthcare and the development of patient care in the UK and Ireland. As such we are pleased to offer support to the organisations and practitioners central to making this happen. KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. Kyowa Kirin International is a subsidiary of Kyowa Kirin Co., Ltd. the Japan-based global specialty pharmaceutical KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is owned by Kyowa Kirin Co., Ltd. of Japan. Founded in 1949, Kyowa Kirin has a successful track record in Japan and is now expanding globally. Our highly successful product portfolio, enviable pipeline and active Business Development group provides a wealth of products in the therapeutic areas of Oncology,CNS and
KYOWA KIRIN INTERNATIONAL Kyowa Kirin Pharma S.R.L. pursuant to Section 54 (1) of the Modern Slavery Act 2015 (the “Act”) and covers the financial year ending 31 December 2019. KKI is a wholly owned subsidiary of Kyowa Kirin Co., Ltd. a company incorporated in Japan and listed on the Tokyo Stock Exchange. The Kyowa Kirin Group is an R&D based pharmaceutical companyKYOWA KIRIN LTD
Welcome to Kyowa Kirin Ltd (UK and Ireland) Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. KYOWA KIRIN INTERNATIONAL Welcome to Kyowa Kirin Denmark. Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. KYOWA KIRIN INTERNATIONAL Kyowa Kirin. A global company committed to taking the walk of life, one life at a time. We bring innovative pharmaceuticals to the world. We are devoted to developing innovative antibody engineering technology by pursuing the truth of life more deeply. "Therapeutic Antibodies" Hopes for the Future. We are driven by state-of-the-artantibody
KYOWA KIRIN INTERNATIONAL Kyowa Kirin è una azienda farmaceutica globale con sede in Giappone, che vuole contribuire alla salute e al benessere attraverso lo sviluppo e la commercializzazione nel mondo di farmaci innovativi, ponendosi all’avanguardia nel settore dell’immunoterapia e della ricerca di nuovi anticorpi terapeutici. HOME - KYOWA KIRIN LTDTRANSLATE THIS PAGE Waar patiënten kunnen gelovenin een toekomst zonder pijn. Commitment to life. One life at a time. Bij Kyowa Kirin geloven we in een wereld waarin niemand hoeft te lijden. We begrijpen dat wij als farmaceut de wereld als geheel niet kunnen veranderen. We kunnen wél die van de patiënt en hun familie en vrienden veranderen. En daar gaat het om. KYOWA KIRIN INTERNATIONAL Here is the top of page. This is the navigation link for moving toward in this page. Go to main contents; Go to footer contents KYOWA KIRIN INTERNATIONAL Nachstehend finden Sie die Kontaktinformationen unserer Kyowa Kirin Niederlassung in der Schweiz. Dr. Kirsten Wittling. Kyowa Kirin Sàrl Rue Philippe-Plantamour 18-20 c/o Intertrust (Suisse) SA KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. Kyowa Kirin International is a subsidiary of Kyowa Kirin Co., Ltd. the Japan-based global specialty pharmaceutical KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is owned by Kyowa Kirin Co., Ltd. of Japan. Founded in 1949, Kyowa Kirin has a successful track record in Japan and is now expanding globally. Our highly successful product portfolio, enviable pipeline and active Business Development group provides a wealth of products in the therapeutic areas of Oncology,CNS and
KYOWA KIRIN INTERNATIONAL Kyowa Kirin Pharma S.R.L. pursuant to Section 54 (1) of the Modern Slavery Act 2015 (the “Act”) and covers the financial year ending 31 December 2019. KKI is a wholly owned subsidiary of Kyowa Kirin Co., Ltd. a company incorporated in Japan and listed on the Tokyo Stock Exchange. The Kyowa Kirin Group is an R&D based pharmaceutical companyKYOWA KIRIN LTD
Welcome to Kyowa Kirin Ltd (UK and Ireland) Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. KYOWA KIRIN INTERNATIONAL Welcome to Kyowa Kirin Denmark. Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. KYOWA KIRIN INTERNATIONAL Kyowa Kirin. A global company committed to taking the walk of life, one life at a time. We bring innovative pharmaceuticals to the world. We are devoted to developing innovative antibody engineering technology by pursuing the truth of life more deeply. "Therapeutic Antibodies" Hopes for the Future. We are driven by state-of-the-artantibody
KYOWA KIRIN INTERNATIONAL Kyowa Kirin è una azienda farmaceutica globale con sede in Giappone, che vuole contribuire alla salute e al benessere attraverso lo sviluppo e la commercializzazione nel mondo di farmaci innovativi, ponendosi all’avanguardia nel settore dell’immunoterapia e della ricerca di nuovi anticorpi terapeutici. HOME - KYOWA KIRIN LTDTRANSLATE THIS PAGE Waar patiënten kunnen gelovenin een toekomst zonder pijn. Commitment to life. One life at a time. Bij Kyowa Kirin geloven we in een wereld waarin niemand hoeft te lijden. We begrijpen dat wij als farmaceut de wereld als geheel niet kunnen veranderen. We kunnen wél die van de patiënt en hun familie en vrienden veranderen. En daar gaat het om. KYOWA KIRIN INTERNATIONAL Here is the top of page. This is the navigation link for moving toward in this page. Go to main contents; Go to footer contents KYOWA KIRIN INTERNATIONAL Nachstehend finden Sie die Kontaktinformationen unserer Kyowa Kirin Niederlassung in der Schweiz. Dr. Kirsten Wittling. Kyowa Kirin Sàrl Rue Philippe-Plantamour 18-20 c/o Intertrust (Suisse) SA KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is owned by Kyowa Kirin Co., Ltd. of Japan. Founded in 1949, Kyowa Kirin has a successful track record in Japan and is now expanding globally. Our highly successful product portfolio, enviable pipeline and active Business Development group provides a wealth of products in the therapeutic areas of Oncology,CNS and
KYOWA KIRIN INTERNATIONAL Kyowa Kirin International announces that it is to expand its headquarters facility in Galashiels. 02 February 2017. Download (309 KB) Ultragenyx and Kyowa Kirin International Announce Marketing Authorisation Application for KRN23 Filed and Accepted for Review by European Medicines Agency. 05 January 2017. PRODUCTS – KYOWA KIRIN LTD All Kyowa Kirin products are produced using cutting-edge manufacturing technology equipment and under our strict quality assurance system and in full compliance with global standards. Please click here to find out more about our products. KYOWA KIRIN INTERNATIONAL Here is the top of page. This is the navigation link for moving toward in this page. Go to main contents; Go to footer contents KYOWA KIRIN INTERNATIONAL The information on this site is intended to be useful and informative for stakeholders in Kyowa Kirin International. Please note that Kyowa Kirin International cannot guarantee the information is accurate and it shall not be liable for any losses or damage that anyone may OUR VALUES – KYOWA KIRIN LTD Our values are the foundation of our success and are reflected in the strength and dedication demonstrated by our team every day. We inspire and challenge our people to think creatively and work together to create a better world and help people live healthier, more fulfilling lives. We cultivate a strong culture and provide a working KYOWA KIRIN INTERNATIONAL Here is the top of page. This is the navigation link for moving toward in this page. Go to main contents; Go to footer contentsWORKING WITH US
Making a real difference today and tomorrow. Kyowa Kirin is focused on building a Global Specialty Pharmaceutical company to be proud of. By embracing innovation, we have been able to develop a cutting edge pipeline of products targeted on therapy areas that currently have few treatment options. This approach makes a real difference to the CONTACT – KYOWA KIRIN LTD For all general enquiries in the United Kingdom and Ireland please contact: T +44 (0) 1896 664000 F +44 (0) 1896 664001 E Kyowa Kirin Ltd. Galabank Business ParkCURRENT VACANCIES
Kyowa Kirin Ltd. Head Office Galabank Business Park Galashiels TD1 1QH United Kingdom. Tel: +44 (0)1896 664 000 Email: KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. Kyowa Kirin International is a subsidiary of Kyowa Kirin Co., Ltd. the Japan-based global specialty pharmaceutical KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is owned by Kyowa Kirin Co., Ltd. of Japan. Founded in 1949, Kyowa Kirin has a successful track record in Japan and is now expanding globally. Our highly successful product portfolio, enviable pipeline and active Business Development group provides a wealth of products in the therapeutic areas of Oncology,CNS and
KYOWA KIRIN INTERNATIONAL Kyowa Kirin Pharma S.R.L. pursuant to Section 54 (1) of the Modern Slavery Act 2015 (the “Act”) and covers the financial year ending 31 December 2019. KKI is a wholly owned subsidiary of Kyowa Kirin Co., Ltd. a company incorporated in Japan and listed on the Tokyo Stock Exchange. The Kyowa Kirin Group is an R&D based pharmaceutical companyKYOWA KIRIN LTD
Welcome to Kyowa Kirin Ltd (UK and Ireland) Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. KYOWA KIRIN INTERNATIONAL Kyowa Kirin è una azienda farmaceutica globale con sede in Giappone, che vuole contribuire alla salute e al benessere attraverso lo sviluppo e la commercializzazione nel mondo di farmaci innovativi, ponendosi all’avanguardia nel settore dell’immunoterapia e della ricerca di nuovi anticorpi terapeutici. KYOWA KIRIN INTERNATIONAL Kyowa Kirin. A global company committed to taking the walk of life, one life at a time. We bring innovative pharmaceuticals to the world. We are devoted to developing innovative antibody engineering technology by pursuing the truth of life more deeply. "Therapeutic Antibodies" Hopes for the Future. We are driven by state-of-the-artantibody
PIPELINE – KYOWA KIRIN LTD Promising pharmaceutical candidates are emerging from our development pipelines. The current status of Kyowa Kirin’s product pipeline can be viewed by clicking the link below. Product pipeline. KYOWA KIRIN INTERNATIONAL Here is the top of page. This is the navigation link for moving toward in this page. Go to main contents; Go to footer contents KYOWA KIRIN INTERNATIONAL Nachstehend finden Sie die Kontaktinformationen unserer Kyowa Kirin Niederlassung in der Schweiz. Dr. Kirsten Wittling. Kyowa Kirin Sàrl Rue Philippe-Plantamour 18-20 c/o Intertrust (Suisse) SA KYOWA KIRIN INTERNATIONAL Kyowa Kirin Farmacêutica, Unipessoal LDA. Avenida da Ilha da Madeira, nº 35I – 2ºA. Restelo Business Center. 1400-203 Lisboa, Portugal. TEL: +351 21 870 0002. Informação Médica ou Informações Gerais: infoPT@kyowakirin.com. Pharmacovigilance: Farmacovigilância –Efeitos adversos:
KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. Kyowa Kirin International is a subsidiary of Kyowa Kirin Co., Ltd. the Japan-based global specialty pharmaceutical KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is owned by Kyowa Kirin Co., Ltd. of Japan. Founded in 1949, Kyowa Kirin has a successful track record in Japan and is now expanding globally. Our highly successful product portfolio, enviable pipeline and active Business Development group provides a wealth of products in the therapeutic areas of Oncology,CNS and
KYOWA KIRIN INTERNATIONAL Kyowa Kirin Pharma S.R.L. pursuant to Section 54 (1) of the Modern Slavery Act 2015 (the “Act”) and covers the financial year ending 31 December 2019. KKI is a wholly owned subsidiary of Kyowa Kirin Co., Ltd. a company incorporated in Japan and listed on the Tokyo Stock Exchange. The Kyowa Kirin Group is an R&D based pharmaceutical companyKYOWA KIRIN LTD
Welcome to Kyowa Kirin Ltd (UK and Ireland) Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. KYOWA KIRIN INTERNATIONAL Kyowa Kirin è una azienda farmaceutica globale con sede in Giappone, che vuole contribuire alla salute e al benessere attraverso lo sviluppo e la commercializzazione nel mondo di farmaci innovativi, ponendosi all’avanguardia nel settore dell’immunoterapia e della ricerca di nuovi anticorpi terapeutici. KYOWA KIRIN INTERNATIONAL Kyowa Kirin. A global company committed to taking the walk of life, one life at a time. We bring innovative pharmaceuticals to the world. We are devoted to developing innovative antibody engineering technology by pursuing the truth of life more deeply. "Therapeutic Antibodies" Hopes for the Future. We are driven by state-of-the-artantibody
PIPELINE – KYOWA KIRIN LTD Promising pharmaceutical candidates are emerging from our development pipelines. The current status of Kyowa Kirin’s product pipeline can be viewed by clicking the link below. Product pipeline. KYOWA KIRIN INTERNATIONAL Here is the top of page. This is the navigation link for moving toward in this page. Go to main contents; Go to footer contents KYOWA KIRIN INTERNATIONAL Nachstehend finden Sie die Kontaktinformationen unserer Kyowa Kirin Niederlassung in der Schweiz. Dr. Kirsten Wittling. Kyowa Kirin Sàrl Rue Philippe-Plantamour 18-20 c/o Intertrust (Suisse) SA KYOWA KIRIN INTERNATIONAL Kyowa Kirin Farmacêutica, Unipessoal LDA. Avenida da Ilha da Madeira, nº 35I – 2ºA. Restelo Business Center. 1400-203 Lisboa, Portugal. TEL: +351 21 870 0002. Informação Médica ou Informações Gerais: infoPT@kyowakirin.com. Pharmacovigilance: Farmacovigilância –Efeitos adversos:
KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is owned by Kyowa Kirin Co., Ltd. of Japan. Founded in 1949, Kyowa Kirin has a successful track record in Japan and is now expanding globally. Our highly successful product portfolio, enviable pipeline and active Business Development group provides a wealth of products in the therapeutic areas of Oncology,CNS and
PRODUCTS – KYOWA KIRIN LTD All Kyowa Kirin products are produced using cutting-edge manufacturing technology equipment and under our strict quality assurance system and in full compliance with global standards. Please click here to find out more about our products. KYOWA KIRIN INTERNATIONAL Kyowa Kirin Pharma S.R.L. pursuant to Section 54 (1) of the Modern Slavery Act 2015 (the “Act”) and covers the financial year ending 31 December 2019. KKI is a wholly owned subsidiary of Kyowa Kirin Co., Ltd. a company incorporated in Japan and listed on the Tokyo Stock Exchange. The Kyowa Kirin Group is an R&D based pharmaceutical company KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is a company with many career avenues in Europe and the US. We need you, with the drive to excel to join us and contribute to our impressive successes and continued growth. KYOWA KIRIN INTERNATIONAL Here is the top of page. This is the navigation link for moving toward in this page. Go to main contents; Go to footer contents KYOWA KIRIN INTERNATIONAL Important Safety Information And Boxed Warning Indication Fareston ® (toremifene citrate) 60 mg Tablets is an estrogen agonist/antagonist for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor-positive or unknown tumors. CRYSVITA PRODUCT MONOGRAPH The recommended starting dose regimen is 0.8mg/kg of body weight, rounded to the nearest 10mg, administered every two weeks. The minimum starting dose is 10 mg up to a maximum dose of 90mg. HOME - KYOWA KIRIN LTDTRANSLATE THIS PAGE Waar patiënten kunnen gelovenin een toekomst zonder pijn. Commitment to life. One life at a time. Bij Kyowa Kirin geloven we in een wereld waarin niemand hoeft te lijden. We begrijpen dat wij als farmaceut de wereld als geheel niet kunnen veranderen. We kunnen wél die van de patiënt en hun familie en vrienden veranderen. En daar gaat het om. KYOWA KIRIN INTERNATIONAL Kyowa Kirin International - Kyowa Kirin Dubai. Below is the contact information for Dubai office. Kyowa Kirin Pharma FZ-LLC. Office 106, Building 49, Dubai Healthcare City, Dubai, United Arab Emirates. PO Box 62468. T: +971 4 581 3700.CURRENT VACANCIES
Kyowa Kirin Ltd. Head Office Galabank Business Park Galashiels TD1 1QH United Kingdom. Tel: +44 (0)1896 664 000 Email: KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. KYOWA KIRIN INTERNATIONAL At Kyowa Kirin International plc "Commitment to Life" is at our core. With over 500 people focused on this purpose we've become a highly successful and rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of innovative medicines for the treatment of unmet therapeutic needs in majorwestern markets.
KYOWA KIRIN LTD
Welcome to Kyowa Kirin Ltd (UK and Ireland) Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. KYOWA KIRIN INTERNATIONAL Welcome to Kyowa Kirin Norway Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. PRODUCTS – KYOWA KIRIN LTD All Kyowa Kirin products are produced using cutting-edge manufacturing technology equipment and under our strict quality assurance system and in full compliance with global standards. KYOWA KIRIN INTERNATIONAL Kyowa Kirin is committed to ensuring that there is no modern slavery or human trafficking in our supply chains or in any part of ourbusiness.
KYOWA KIRIN INTERNATIONAL Kyowa Kirin nel mondo Con più di 7.000 persone impiegate nel mondo dalla Società, Kyowa Kirin ha attività commerciali e di ricerca e sviluppo in Giappone, Asia, Europa e Medio Oriente, Nord America con una sede operativa negli Stati Uniti. PIPELINE – KYOWA KIRIN LTD Kyowa Kirin Ltd. Head Office Galabank Business Park Galashiels TD1 1QH United Kingdom. Tel: +44 (0)1896 664 000 Email: KYOWA KIRIN INTERNATIONAL Here is the top of page. This is the navigation link for moving toward in this page. Go to main contents; Go to footer contents KYOWA KIRIN INTERNATIONAL Nachstehend finden Sie die Kontaktinformationen unserer Kyowa Kirin Niederlassung in der Schweiz. Dr. Kirsten Wittling. Kyowa Kirin Sàrl Rue Philippe-Plantamour 18-20 c/o Intertrust (Suisse) SA KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. KYOWA KIRIN INTERNATIONAL At Kyowa Kirin International plc "Commitment to Life" is at our core. With over 500 people focused on this purpose we've become a highly successful and rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of innovative medicines for the treatment of unmet therapeutic needs in majorwestern markets.
KYOWA KIRIN LTD
Welcome to Kyowa Kirin Ltd (UK and Ireland) Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. KYOWA KIRIN INTERNATIONAL Welcome to Kyowa Kirin Norway Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. PRODUCTS – KYOWA KIRIN LTD All Kyowa Kirin products are produced using cutting-edge manufacturing technology equipment and under our strict quality assurance system and in full compliance with global standards. KYOWA KIRIN INTERNATIONAL Kyowa Kirin is committed to ensuring that there is no modern slavery or human trafficking in our supply chains or in any part of ourbusiness.
KYOWA KIRIN INTERNATIONAL Kyowa Kirin nel mondo Con più di 7.000 persone impiegate nel mondo dalla Società, Kyowa Kirin ha attività commerciali e di ricerca e sviluppo in Giappone, Asia, Europa e Medio Oriente, Nord America con una sede operativa negli Stati Uniti. PIPELINE – KYOWA KIRIN LTD Kyowa Kirin Ltd. Head Office Galabank Business Park Galashiels TD1 1QH United Kingdom. Tel: +44 (0)1896 664 000 Email: KYOWA KIRIN INTERNATIONAL Here is the top of page. This is the navigation link for moving toward in this page. Go to main contents; Go to footer contents KYOWA KIRIN INTERNATIONAL Nachstehend finden Sie die Kontaktinformationen unserer Kyowa Kirin Niederlassung in der Schweiz. Dr. Kirsten Wittling. Kyowa Kirin Sàrl Rue Philippe-Plantamour 18-20 c/o Intertrust (Suisse) SA KYOWA KIRIN INTERNATIONAL At Kyowa Kirin International plc "Commitment to Life" is at our core. With over 500 people focused on this purpose we've become a highly successful and rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of innovative medicines for the treatment of unmet therapeutic needs in majorwestern markets.
PRODUCTS – KYOWA KIRIN LTD All Kyowa Kirin products are produced using cutting-edge manufacturing technology equipment and under our strict quality assurance system and in full compliance with global standards. KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is a company with many career avenues in Europe and the US. We need you, with the drive to excel to join us and contribute to our impressive successes and continued growth. KYOWA KIRIN INTERNATIONAL Here is the top of page. This is the navigation link for moving toward in this page. Go to main contents; Go to footer contents KYOWA KIRIN INTERNATIONAL Kyowa Kirin is committed to ensuring that there is no modern slavery or human trafficking in our supply chains or in any part of ourbusiness.
HOME - KYOWA KIRIN LTDTRANSLATE THIS PAGE Commitment to life. One life at a time. Bij Kyowa Kirin geloven we in een wereld waarin niemand hoeft te lijden. We begrijpen dat wij als farmaceut de wereld als geheel niet kunnen veranderen. KYOWA KIRIN INTERNATIONAL Important Safety Information And Boxed Warning Indication Fareston ® (toremifene citrate) 60 mg Tablets is an estrogen agonist/antagonist for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor-positive or unknown tumors. CRYSVITA PRODUCT MONOGRAPH The recommended starting dose regimen is 0.8mg/kg of body weight, rounded to the nearest 10mg, administered every two weeks. The minimum starting dose is 10 mg up to a maximum dose of 90mg.CURRENT VACANCIES
Kyowa Kirin Ltd. Head Office Galabank Business Park Galashiels TD1 1QH United Kingdom. Tel: +44 (0)1896 664 000 Email: KYOWA KIRIN INTERNATIONAL Below is the contact information for Dubai office. Kyowa Kirin Pharma FZ-LLC Office 106, Building 49, Dubai Healthcare City, Dubai, UnitedArab Emirates.
KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. Kyowa Kirin International is a subsidiary of Kyowa Kirin Co., Ltd. the Japan-based global specialty pharmaceutical KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is owned by Kyowa Kirin Co., Ltd. of Japan. Founded in 1949, Kyowa Kirin has a successful track record in Japan and is now expanding globally. Our highly successful product portfolio, enviable pipeline and active Business Development group provides a wealth of products in the therapeutic areas of Oncology,CNS and
KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is a company with many career avenues in Europe and the US. We need you, with the drive to excel to join us and contribute to our impressive successes and continued growth. KYOWA KIRIN INTERNATIONAL Kyowa Kirin Pharma S.R.L. pursuant to Section 54 (1) of the Modern Slavery Act 2015 (the “Act”) and covers the financial year ending 31 December 2019. KKI is a wholly owned subsidiary of Kyowa Kirin Co., Ltd. a company incorporated in Japan and listed on the Tokyo Stock Exchange. The Kyowa Kirin Group is an R&D based pharmaceutical companyKYOWA KIRIN LTD
Welcome to Kyowa Kirin Ltd (UK and Ireland) Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. KYOWA KIRIN INTERNATIONAL Kyowa Kirin è una azienda farmaceutica globale con sede in Giappone, che vuole contribuire alla salute e al benessere attraverso lo sviluppo e la commercializzazione nel mondo di farmaci innovativi, ponendosi all’avanguardia nel settore dell’immunoterapia e della ricerca di nuovi anticorpi terapeutici. KYOWA KIRIN INTERNATIONAL Kyowa Kirin. A global company committed to taking the walk of life, one life at a time. We bring innovative pharmaceuticals to the world. We are devoted to developing innovative antibody engineering technology by pursuing the truth of life more deeply. "Therapeutic Antibodies" Hopes for the Future. We are driven by state-of-the-artantibody
PIPELINE – KYOWA KIRIN LTD Promising pharmaceutical candidates are emerging from our development pipelines. The current status of Kyowa Kirin’s product pipeline can be viewed by clicking the link below. Product pipeline. KYOWA KIRIN INTERNATIONAL Here is the top of page. This is the navigation link for moving toward in this page. Go to main contents; Go to footer contents KYOWA KIRIN INTERNATIONAL Kyowa Kirin Farmacêutica, Unipessoal LDA. Avenida da Ilha da Madeira, nº 35I – 2ºA. Restelo Business Center. 1400-203 Lisboa, Portugal. TEL: +351 21 870 0002. Informação Médica ou Informações Gerais: infoPT@kyowakirin.com. Pharmacovigilance: Farmacovigilância –Efeitos adversos:
KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. Kyowa Kirin International is a subsidiary of Kyowa Kirin Co., Ltd. the Japan-based global specialty pharmaceutical KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is owned by Kyowa Kirin Co., Ltd. of Japan. Founded in 1949, Kyowa Kirin has a successful track record in Japan and is now expanding globally. Our highly successful product portfolio, enviable pipeline and active Business Development group provides a wealth of products in the therapeutic areas of Oncology,CNS and
KYOWA KIRIN INTERNATIONAL Kyowa Kirin International plc is a company with many career avenues in Europe and the US. We need you, with the drive to excel to join us and contribute to our impressive successes and continued growth. KYOWA KIRIN INTERNATIONAL Kyowa Kirin Pharma S.R.L. pursuant to Section 54 (1) of the Modern Slavery Act 2015 (the “Act”) and covers the financial year ending 31 December 2019. KKI is a wholly owned subsidiary of Kyowa Kirin Co., Ltd. a company incorporated in Japan and listed on the Tokyo Stock Exchange. The Kyowa Kirin Group is an R&D based pharmaceutical companyKYOWA KIRIN LTD
Welcome to Kyowa Kirin Ltd (UK and Ireland) Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. KYOWA KIRIN INTERNATIONAL Kyowa Kirin è una azienda farmaceutica globale con sede in Giappone, che vuole contribuire alla salute e al benessere attraverso lo sviluppo e la commercializzazione nel mondo di farmaci innovativi, ponendosi all’avanguardia nel settore dell’immunoterapia e della ricerca di nuovi anticorpi terapeutici. KYOWA KIRIN INTERNATIONAL Kyowa Kirin. A global company committed to taking the walk of life, one life at a time. We bring innovative pharmaceuticals to the world. We are devoted to developing innovative antibody engineering technology by pursuing the truth of life more deeply. "Therapeutic Antibodies" Hopes for the Future. We are driven by state-of-the-artantibody
PIPELINE – KYOWA KIRIN LTD Promising pharmaceutical candidates are emerging from our development pipelines. The current status of Kyowa Kirin’s product pipeline can be viewed by clicking the link below. Product pipeline. KYOWA KIRIN INTERNATIONAL Here is the top of page. This is the navigation link for moving toward in this page. Go to main contents; Go to footer contents KYOWA KIRIN INTERNATIONAL Kyowa Kirin Farmacêutica, Unipessoal LDA. Avenida da Ilha da Madeira, nº 35I – 2ºA. Restelo Business Center. 1400-203 Lisboa, Portugal. TEL: +351 21 870 0002. Informação Médica ou Informações Gerais: infoPT@kyowakirin.com. Pharmacovigilance: Farmacovigilância –Efeitos adversos:
PRODUCTS – KYOWA KIRIN LTD All Kyowa Kirin products are produced using cutting-edge manufacturing technology equipment and under our strict quality assurance system and in full compliance with global standards. Please click here to find out more about our products. KYOWA KIRIN INTERNATIONAL Kyowa Kirin Pharma S.R.L. pursuant to Section 54 (1) of the Modern Slavery Act 2015 (the “Act”) and covers the financial year ending 31 December 2019. KKI is a wholly owned subsidiary of Kyowa Kirin Co., Ltd. a company incorporated in Japan and listed on the Tokyo Stock Exchange. The Kyowa Kirin Group is an R&D based pharmaceutical company KYOWA KIRIN INTERNATIONAL Important Safety Information And Boxed Warning Indication Fareston ® (toremifene citrate) 60 mg Tablets is an estrogen agonist/antagonist for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor-positive or unknown tumors. KYOWA KIRIN INTERNATIONAL Here is the top of page. This is the navigation link for moving toward in this page. Go to main contents; Go to footer contents KYOWA KIRIN INTERNATIONAL The information on this site is intended to be useful and informative for stakeholders in Kyowa Kirin International. Please note that Kyowa Kirin International cannot guarantee the information is accurate and it shall not be liable for any losses or damage that anyone may KYOWA KIRIN INTERNATIONAL Kyowa Kirin International - Kyowa Kirin Dubai. Below is the contact information for Dubai office. Kyowa Kirin Pharma FZ-LLC. Office 106, Building 49, Dubai Healthcare City, Dubai, United Arab Emirates. PO Box 62468. T: +971 4 581 3700. OUR VALUES – KYOWA KIRIN LTD Our values are the foundation of our success and are reflected in the strength and dedication demonstrated by our team every day. We inspire and challenge our people to think creatively and work together to create a better world and help people live healthier, more fulfilling lives. We cultivate a strong culture and provide a working HOME - KYOWA KIRIN LTDTRANSLATE THIS PAGE Waar patiënten kunnen gelovenin een toekomst zonder pijn. Commitment to life. One life at a time. Bij Kyowa Kirin geloven we in een wereld waarin niemand hoeft te lijden. We begrijpen dat wij als farmaceut de wereld als geheel niet kunnen veranderen. We kunnen wél die van de patiënt en hun familie en vrienden veranderen. En daar gaat het om. KYOWA KIRIN INTERNATIONAL Nachstehend finden Sie die Kontaktinformationen unserer Kyowa Kirin Niederlassung in der Schweiz. Dr. Kirsten Wittling. Kyowa Kirin Sàrl Rue Philippe-Plantamour 18-20 c/o Intertrust (Suisse) SACURRENT VACANCIES
Kyowa Kirin Ltd. Head Office Galabank Business Park Galashiels TD1 1QH United Kingdom. Tel: +44 (0)1896 664 000 Email:* Who we are
* In numbers
* Our philosophy
* Core values
* At a glance
* Global network
* Careers
* What we do
* Areas of focus
* Technology-driven drug discovery* Main products
* Pipeline
* Around the world
* Partnerships
* Sustainability
* Management Philosophy and CSV Management * Our approach to Sustainability* Group Policies
* Media center
* Latest News
* Videos
* Careers
* Investor relations*
*
* open menu
KYOWA KIRIN WORLDWIDEJAPANOPEN
* Kyowa Kirin Co., Ltd. ( 日本語)
* FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd. ( 日本語/ English
)
* Kyowa Kirin plus Co., Ltd. ( 日本語)
* Kyowa Kirin Frontier Co., Ltd. ( 日本語)
NORTH AMERICAOPEN
* Kyowa Kirin USA Holdings, Inc. ( English)
* BioWa, Inc. ( English ) * Kyowa Kirin, Inc. ( English )ASIA PACIFICOPEN
* Kyowa Kirin Asia Pacific Pte. Ltd. ( English)
* Kyowa Kirin China Pharmaceutical Co., Ltd.( 中文)
* Kyowa Kirin Korea Co., Ltd. ( 한국어 ) * Kyowa Kirin Taiwan Co., Ltd. ( 中文 ) * Kyowa Kirin Hong Kong Co., Limited ( 中文 /English )
* Kyowa Kirin (Thailand) Co., Ltd. ( ภาษาไทย)
* Kyowa Kirin Australia Pty Ltd. ( English ) * Kyowa Kirin Malaysia Sdn. Bhd. ( English )EMEAOPEN
* Kyowa Kirin International plc ( English)
* Kyowa Kirin Ltd. ( English)
* Kyowa Kirin Pharma SAS ( français ) * Kyowa Kirin Farmaceutica, S.L.U. ( Español)
* Kyowa Kirin GmbH ( Deutsch)
* Kyowa Kirin Pharma B.V. - Netherlands ( Nederlands)
* Kyowa Kirin Pharma B.V. - Belgium & Luxembourg ( English)
* Kyowa Kirin S.r.l. - Italia ( Italiano)
* Kyowa Kirin AB - Sweden ( Svenska)
* Kyowa Kirin AB - Norway ( English)
* Kyowa Kirin AB - Finland ( English)
* Kyowa Kirin AB - Denmark ( English)
*
*
* Who we areopen
Who we are TOP
* In numbers
* Our philosophy
* Core values
* At a glance
* Global network
* Careers
* What we doopen
What we do TOP
* Areas of focus
* Technology-driven drug discovery* Main products
* Pipeline
* Around the world
* Partnerships
* SustainabilityopenSustainability TOP
* Management Philosophy and CSV Management * Our approach to Sustainability* Group Policies
* Media centeropen
Media center TOP
* Latest News
* Videos
* Careers
* Investor relationsDELIVERING
LIFE-CHANGING
VALUE
AS A GLOBAL SPECIALTY PHARMACEUTICAL COMPANYNOTICE
* July 13, 2020 White Paper on the Unrecognized Burden of XLH inAdults in Europe
SEE MORE
NEWS RELEASES
This website uses JavaScript to display a part of contents. Please enable JavaScript in your browser to correctly veiw ourwebsite.
* June 3, 2021 Kyowa Kirin Announces Changes to its Organization (204KB) * June 1, 2021 AMGEN AND KYOWA KIRIN TO JOINTLY DEVELOP AND COMMERCIALIZE KHK4083, A PHASE 3-READY, POTENTIAL FIRST-IN-CLASS TREATMENT FOR ATOPIC DERMATITIS (140KB) * May 20, 2021 MEI Pharma and Kyowa Kirin Announce New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting2021 (362KB)
SEE MORE
IN NUMBERS
click to close window pauseOUR PHILOSOPHY
The Kyowa Kirin Group companiesstrive to
contribute to the health and well-being of people aroundthe world by
creating new value through the pursuit of advances in life sciences and technologies.CORE VALUES
Our goal is clear: to do everything we can to answer the unmet medical needs of patients, their families, and medical professionals, and to do it as quickly as possible. Because every moment counts. Our values are a way of thinking and attitude that supports the activity of each officer and employee belonging to the Kyowa Kirin Group. It consists of core concept "Commitment to Life" and three key words.close
Countless precious lives surround us. Brought into this world, blessed, raised with loving care - full of dreams, happiness as the goal of life. Deeply instill in us, and know that what we work for - the most precious presence of all on this planet. Infinite possibilities for us, a pharmaceutical company. Believe in ourselves, believe in our power, believe in what we havebuilt together.
Not a large company, but with qualities like none other. History so unique we can be proud of technology unmatched, And superior human beings that cannot be found elsewhere. Be brave; do not shy away from challenges. Have passion; break away from the norm. Innovation is not just about growth - but instead a leap towards the future, a grand growth with wings. Wings never to be given to those who settle for the status-quo. Don't just make medicine. Make people smile, bring light to theirlives.
How strongly one longs to live. How deeply one is loved by their lovedones.
How sincerely one desires to help the one life they dedicate themselves to in the field of medicine. Stay receptive, sharpen your sensitivities. Let us become the top company in the world who cares the most forlife.
Strength is not what saves the world. A caring heart is what the worldcalls for.
Strive to become a superb team. One human being, excellent or not, is ever so powerless, as a power of one, mistakes, even a possibility. Show the world the excellence of coming together. Amazing results,when we become one.
Be driven. Think of those fighting for their lives every day. Their strong devotion to life speaks to our hearts. Hurry - do not scurry, but we must not stand still. Stay sincere, always - may that be our vow. We make medicine. This is, our walk of life. Work, can bring happiness. Remember this, always. Born on this planet in various parts of the globe, passing through life in different ways, And like a miracle we found one another - our jobs, our team, ourcompany.
Know this, and be fulfilled, always. Be thankful of what you have, pour your heart and soul into the mission you were given, Be proud of your work, the work to save precious lives. We are, each and everyone of us, Kyowa Kirin. Taking the walk of life,one life at a time.
close
AT A GLANCE
Find out more about our company and ourcommitment
to making positive contributionsin human health and
community welfare.
Managementopen
Productsmove to page Research & Developmentmove to page Governancemove to pageHistorymove to page
Overviewmove to page Sustainabilitymove to page MIRAI PORTmove to page Corporate videomove to page close DIRECTORS & OFFICERSCEO message
Under our management philosophy of "the Kyowa Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies", and as a Japan-based Global Specialty Pharmaceutical Company, we are striving to utilize diverse drug discovery technologies, such as our unique antibody technologies, to discover innovative new drugs that will make patients and theircaregivers smile.
We have designated as our vision for 2030, "Kyowa Kirin will realize the successful creation and delivery of life-changing value that ultimately makes people smile, as a Japan-based Global Specialty Pharmaceutical company built on the diverse team of experts with shared passion for innovation". Around the world, there are still many diseases lacking effective treatment and various medical issues that cause suffering and concern to patients and medical professionals. In Kyowa Kirin, we are working to foster diverse teams whose mission it is to tackle these issues. Their active participation in these teams to work towards our vision continues to propel the company forward. By identifying unmet medical needs and creating new pharmaceuticals and solutions to meet those needs, and by innovating across the company, it is Kyowa Kirin’s aim to create life-changing value that brings smiles to people suffering from disease and gives them hope that their lives can change dramatically for the better. Moreover, the world is currently facing a number of issues, such as threats from climate change, damage to biodiversity, a lack of energy security and various types of inequality. We at Kyowa Kirin believe we should respond to these issues by taking actions based around SDGs (Sustainable Development Goals). Through our pharmaceuticals business, we will contribute to improving the lives of people suffering from disease and address the issues facing the world. Going forward, everyone at Kyowa Kirin will continue to work together for the health and well-being of people around the world. Representative Director of the Board President and Chief Executive OfficerMasashi Miyamoto
close DIRECTORS & OFFICERSGLOBAL NETWORK
Kyowa Kirin Group companies are dedicated to improving quality of life by answeringthe unmet medical
needs of people worldwide. KYOWA KIRIN CO., LTD.JAPAN KYOWA KIRIN ASIA PACIFIC PTE. LTD.SINGAPORE - ASIA PACIFIC KYOWA KIRIN INTERNATIONAL PLC.UK - EMEA KYOWA KIRIN USA HOLDINGS, INC.USA - NORTH AMERICA KYOWA KIRIN CO., LTD.JAPAN Visit the website(日本語) * Subsidiaries in Japan: Kyowa Medical Promotion Co., Ltd. Kyowa Kirin plus Co., Ltd.(日本語)
Kyowa Media Service Co., Ltd. Kyowa Iryo Kaihatsu Co., Ltd. FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd.(日本語
/ English
)
Kyowa Kirin Frontier Co., Ltd.(日本語)
close panel
KYOWA KIRIN ASIA PACIFIC PTE. LTD.SINGAPORE - ASIA PACIFIC Visit the website(English) * Subsidiaries in Asia Pacific: Kyowa Kirin China PharmaceuticalCo., Ltd.
(China: 中文 /
English )
Kyowa Kirin Korea Co., Ltd. (Korea: 한국어 ) Kyowa Kirin Taiwan Co., Ltd.(Taiwan: 中文 )
Kyowa Kirin Hong Kong Co., Limited (Hong Kong: 中文 /English )
Kyowa Kirin (Thailand) Co., Ltd. (Thailand: ภาษาไทย)
Kyowa Kirin Australia Pty Ltd.(English)
Kyowa Kirin Malaysia Sdn. Bhd.(English)
close panel
KYOWA KIRIN INTERNATIONAL PLC.UK - EMEAVisit the website
* Subsidiaries in EMEA: Kyowa Kirin Ltd. (UK: English ) Kyowa Kirin Pharma SAS (français) Kyowa Kirin Farmaceutica, S.L.U. (Spain: Español)
Kyowa Kirin GmbH (Germany: Deutsch)
Kyowa Kirin Pharma B.V. (Netherlands: Nederlands)
Kyowa Kirin Pharma B.V. (Belgium + Luxembourg: English)
Kyowa Kirin S.r.l. (Italy: Italiano)
Kyowa Kirin AB (Sweden: Svenska)
Kyowa Kirin AB (Norway: English)
Kyowa Kirin AB (Finland: English)
Kyowa Kirin AB (Denmark: English)
close panel
KYOWA KIRIN USA HOLDINGS, INC.USA - NORTH AMERICA Visit the website(English) * Subsidiaries in North America: BioWa, Inc. (USA: English ) Kyowa Kirin, Inc. (USA: English)
close panel
CAREERS
Our best results come from our people. As a Japan-based global specialty pharmaceutical company, Kyowa Kirin will continue to contribute to the health andwellbeing of
people around the world.LEARN MORE
The Story of Basic Immunology* About us
* Research & DevelopmentR & D* Sustainability
* News & Releases
* Careers
* Investor relations* Worldwide
* Contact us
* Sitemap
* Terms & Conditions* Privacy policy
Copyright © Kyowa Kirin Co., Ltd. All rights reserved.Close
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0